Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot Study
Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot Study
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
ATTR-CM is becoming more prevalent, and disease-modifying therapy has been investigated in recent years with promising results. Diflunisal has shown TTR-stabilizing properties assessed by biomarkers and echocardiography, but there are no trials addressing the evolution of morphological changes with CMR.
AMILCA-DIFLU is an exploratory pilot study...
Alternative Titles
Full title
Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3104541968
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3104541968
Other Identifiers
ISSN
2077-0383
E-ISSN
2077-0383
DOI
10.3390/jcm13175032
